Replies to post #826735 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

>>For example, a report intended to identify potential instances of “wash sales”—trading
involving no change in beneficial ownership that is intended to produce the false appearance of
trading24—may have captured transactions where the same beneficial owner rapidly purchased and then sold the same security at the same price.

>> Pump & Dump Report: Canaccord’s monthly Pump & Dump Report was similarly not
reasonably designed or implemented. At the beginning of the Relevant Time Period, the report used by Canaccord’s market making business only reflected transactions with a 25% price movement that 13 occurred in a single day.

>> Red flags commonly observed at onboarding include, among other things, inconsistent identification details, complex
ownership structures, and reluctance to provide necessary information.

[brazen22]

I’m trying to follow your point. If Canaccord was the “sacrificial lamb,” that can cut more than one way. It could mean NWBO had leverage, but it could also mean Canaccord was simply the easiest or cheapest defendant to resolve.

A settlement does not prove the remaining defendants are doomed, and it does not validate the billion dollar damage theories. If anything, an early settlement with funds placed in escrow sounds more like practical resolution than proof of a jackpot.

If NWBO truly had Canaccord dead to rights for massive damages, why settle instead of pressing the advantage?